Retirement Guys Formula LLC grew its stake in Galectin Therapeutics Inc. (NASDAQ:GALT – Free Report) by 87.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,500 shares of the company’s stock after buying an additional 10,000 shares during the quarter. Retirement Guys Formula LLC’s […]
Retirement Guys Formula LLC grew its stake in shares of Galectin Therapeutics Inc. (NASDAQ:GALT – Free Report) by 87.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,500 shares of the company’s stock after buying an additional 10,000 shares […]
StockNews.com began coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) in a report released on Sunday. The brokerage issued a hold rating on the stock. Separately, HC Wainwright reissued a buy rating and issued a $11.00 target price on shares of Galectin Therapeutics in a research note on Tuesday, August 15th. Get Our […]
StockNews.com assumed coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) in a research report released on Sunday morning. The brokerage issued a hold rating on the stock. Separately, HC Wainwright restated a buy rating and issued a $11.00 target price on shares of Galectin Therapeutics in a research note on Tuesday, August 15th. […]
StockNews.com began coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) in a research note issued to investors on Friday. The brokerage issued a hold rating on the stock. Separately, HC Wainwright reaffirmed a buy rating and issued a $11.00 target price on shares of Galectin Therapeutics in a research report on Tuesday, August […]